Bexarotene, one of the small molecules predicted for target RXRA gene, can improve cholesterol homeostasis and inhibit atherosclerosis progression in a mouse model of mixed dyslipidemia (Lalloyer et al., 2006). This evidence concerns the gene RXRA and atherosclerosis.